Tg Therapeutics (TGTX) EBT Margin (2017 - 2026)
Tg Therapeutics (TGTX) posted quarterly EBT Margin of 9.94% for Q1 2026, up 541.0% year-over-year from 1.55% in Q1 2025, and down 57.89% quarter-over-quarter from 23.6% in Q4 2025.
Powered by 
Analysis
Tg Therapeutics (TGTX) EBT Margin (2017 - 2026) Analysis & Trends
Tg Therapeutics' EBT Margin history runs 10 years deep, the most recent figure standing at 9.94% for Q1 2026.
- In Q1 2026, EBT Margin rose 541.0% year-over-year to 9.94%; the TTM figure through Mar 2026 stood at 17.51% (up 648.0% YoY), while the FY2025 annual figure was 17.48%, up 944.0% from the prior year.
- EBT Margin for Q1 2026 stood at 9.94%, down from 23.6% in the prior quarter.
- The five-year high for EBT Margin was 68.71% in Q3 2023, with the low at 94568.75% in Q4 2022.
- The 5-year median for EBT Margin is 4.52% (2025), against an average of 8941.43%.
- The sharpest annual moves came in 2022 and 2023: EBT Margin slumped 9043747 bps in 2022, then soared 9453685 bps in 2023.
- Tg Therapeutics' EBT Margin stood at 94568.75% in 2022, then surged by 100 bps to 31.9% in 2023, then soared by 176 bps to 24.34% in 2024, then slipped by 3 bps to 23.6% in 2025, then tumbled by 58 bps to 9.94% in 2026.
- Business Quant data shows TGTX's EBT Margin at 9.94% in Q1 2026, 23.6% in Q4 2025, and 16.02% in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 35.78% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -528.97% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 18.33% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 13.77% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -2.67% |
| 10 | Tg Therapeutics | 7.97 Bn | 7.29 Bn | 199.14 Mn | 4.26% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.26% |
| Mar 31, 2026 | 9.94% |
| Dec 31, 2025 | 23.60% |
| Sep 30, 2025 | 16.02% |
| Jun 30, 2025 | 21.91% |
| Mar 31, 2025 | 4.52% |
| Dec 31, 2024 | 24.34% |
| Sep 30, 2024 | 5.09% |
| Jun 30, 2024 | 8.92% |
| Mar 31, 2024 | -16.82% |
| Dec 31, 2023 | -30.71% |
| Sep 30, 2023 | 68.71% |
| Jun 30, 2023 | -296.19% |
| Mar 31, 2023 | -502.78% |
| Dec 31, 2022 | -100,501.25% |
| Sep 30, 2022 | -38,947.87% |
| Jun 30, 2022 | -7,063.64% |
| Mar 31, 2022 | -3,449.21% |
| Dec 31, 2021 | -4,051.10% |
| Sep 30, 2021 | -4,244.63% |